img

Patient Registry Software Market By Registry (Disease Registries, Health Service Registries, and Product Registries), By Software (Stand-alone Software and Integrated Software), By End User (Hospitals, Government Organizations and Third Party Administrators (TPAs), and Pharmaceutical, Biotechnology, and Medical Device Companies, and Other), Global Analysis to 2023


Published on: 2024-07-07 | No of Pages : 240 | Industry : Media and IT

Publisher : MRA | Format : PDF&Excel

Patient Registry Software Market By Registry (Disease Registries, Health Service Registries, and Product Registries), By Software (Stand-alone Software and Integrated Software), By End User (Hospitals, Government Organizations and Third Party Administrators (TPAs), and Pharmaceutical, Biotechnology, and Medical Device Companies, and Other), Global Analysis to 2023

Patient Registry Software Market By Registry (Disease Registries, Health Service Registries, and Product Registries), By Software (Stand-alone Software and Integrated Software), By End User (Hospitals, Government Organizations and Third Party Administrators (TPAs), and Pharmaceutical, Biotechnology, and Medical Device Companies, and Other), Global Analysis to 2023

Patient Registry Software Market Valuation – 2024-2031

According to the new report titled " Patient Registry Software Market By Registry (Disease Registries, Health Service Registries, and Product Registries), By Software (Stand-alone Software and Integrated Software), By End User (Hospitals, Government Organizations and Third Party Administrators (TPAs), and Pharmaceutical, Biotechnology, and Medical Device Companies, and Other), Global Analysis to 2023"

The valuation of the Patient Registry Software market was $1.53 Billion in 2023 and is projected to reach $5.09 Billion by 2032, at a CAGR of 12.47% from 2021 to 2032.

The Patient Registry Software Market was valued at $1.53 Billion by 2023 and expected to grow at CAGR of 12.47% over forecast period.  Patient registry software is a type of healthcare information technology solution designed to collect, store, manage, and analyze data related to patients with specific medical conditions, diseases, or demographic characteristics. These registries serve as valuable tools for healthcare organizations, researchers, and policymakers to track patient outcomes, monitor disease trends, evaluate treatment effectiveness, and support clinical research efforts. Patient registry software enables healthcare organizations and research institutions to collect and analyze large volumes of patient data to identify trends, evaluate treatment outcomes, and generate real-world evidence. As the importance of evidence-based medicine continues to rise, there is a growing demand for robust patient registry solutions to support clinical research and post-market surveillance studies. Chronic diseases such as diabetes, cardiovascular disease, cancer, and respiratory conditions pose significant challenges to healthcare systems worldwide. Patient registry software plays a critical role in managing chronic diseases by tracking patient demographics, disease progression, treatment adherence, and health outcomes over time. Healthcare providers use registry data to implement personalized care plans, monitor disease trends, and improve population health management strategies.

Disease Registries held the largest share in the Patient Registry Software market

By Registry (Disease Registries, Health Service Registries, and Product Registries) where Flavored Drinks plays a crucial role in the Patient Registry Software market. Disease registries are centralized databases or repositories that systematically collect, store, and manage information about individuals diagnosed with specific diseases or medical conditions. These registries serve various purposes, including epidemiological research, clinical studies, quality improvement initiatives, and public health surveillance efforts. Disease registries are valuable tools for conducting observational studies, clinical trials, and comparative effectiveness research. Researchers use registry data to investigate disease etiology, risk factors, treatment outcomes, and long-term prognosis. As the importance of evidence-based medicine continues to rise, there is a growing demand for robust disease registries to support clinical research and inform clinical decision-making. Healthcare organizations use disease registries to monitor and improve the quality of care by tracking clinical outcomes, adherence to clinical guidelines, and healthcare performance metrics. Registries provide data-driven insights to identify variations in care, implement best practices, and optimize treatment strategies, ultimately improving patient safety and health outcomes.

North America headed the Patient Registry Software market in 2023


North America is a hub for clinical research and evidence-based medicine, with a strong emphasis on collecting and analyzing patient data to inform healthcare decision-making. Patient registry software facilitates the creation and management of disease-specific registries, supporting observational studies, clinical trials, and comparative effectiveness research across various medical specialties. Chronic diseases such as diabetes, cardiovascular disease, cancer, and respiratory conditions are major contributors to morbidity and mortality in North America. Patient registry software plays a crucial role in managing chronic diseases by tracking patient demographics, disease progression, treatment adherence, and health outcomes over time. Healthcare providers use registry data to implement personalized care plans, monitor disease trends, and improve population health management strategies. Patient registry software facilitates public health surveillance efforts by tracking disease prevalence, incidence, and trends over time. Registries help public health authorities monitor disease outbreaks, assess the impact of preventive interventions, and allocate resources effectively to address emerging health threats, such as infectious diseases, chronic diseases, and environmental exposures.

Key market players operating in the market that are profiled in the report are

 IBM Corporation (US), Cerner Corporation (US), McKesson Corporation (US), IQVIA Holdings Inc. (US), Optum, Inc. (US), Allscripts Healthcare Solutions, Inc. (US), Epic Systems Corporation (US) etc.

Report Scope

REPORT ATTRIBUTES DETAILS
STUDY PERIOD

2018-2031

GROWTH RATE

CAGR of ~13.89% from 2024 to 2031

BASE YEAR FOR VALUATION

2023

HISTORICAL PERIOD

2018-2022

FORECAST PERIOD

2024-2031

QUANTITATIVE UNITS

Value in USD Billion

REPORT COVERAGE

Historical and Forecast Revenue Forecast, Historical and Forecast Volume, Growth Factors, Trends, Competitive Landscape, Key Players, Segmentation Analysis

SEGMENTS COVERED
  • Product
  • Deployment Model
  • Software Type
  • Functionality
  • End- User
REGIONS COVERED
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
KEY PLAYERS

IQVIA, IBM Watson Health, Cerner Corporation, Epic Systems Corporation, Phytel, OpenText, Global Vision Technologies, Dacima Software, Inc., Velos, Inc., Syapse

CUSTOMIZATION

Report customization along with purchase available upon request

Keyplayer

  • IQVIA
  • IBM Watson Health
  • Cerner Corporation
  • Epic Systems Corporation
  • Phytel
  • OpenText
  • Global Vision Technologies
  • Dacima Software
  • Inc.
  • Velos
  • Inc.
  • Syapse
  • Premier
  • Inc.
  • Medstreaming
  • FIGmd
  • ArborMetrix
  • Optum
  • Inc.
  • Arbor Research Collaborative for Health
  • Health Catalyst
  • Conduent
  • Inc.
  • ArborMetrix
  • VersaForm Systems Corporation 

Patient Registry Software Market, By Category

Product

  • Disease Registry
  • Health Service Registry
  • Product Registry

Deployment Model

  • On-premise
  • Web/Cloud-based

Software Type

  • Standalone
  • Integrated

Functionality

  • Population Health Management
  • Health Information Exchange
  • Patient Care Management
  • Point-Of-Care
  • Medical Research & Clinical Studies
  • Product Outcome Evaluation

End-User

  • Government & Tthird party
  • Hospitals & Mmedical Ppractices
  • Private Ppayers
  • Pharma & Mmedical Ddevice Ccompanies
  • Research Oorganization
  • Banking, Financial Services, and Insurance (BFSI)
  • Retail and E-Commerce

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Table of Content

1 INTRODUCTION OF GLOBAL PATIENT REGISTRY SOFTWARE MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL PATIENT REGISTRY SOFTWARE MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE
5.1 Overview
5.2 Standalone
5.3 Integrated

6 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL
6.1 Overview
6.2 On premise
6.3 Web/Cloud- based

7 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT
7.1 Overview
7.2 Disease Registry
7.3 Health Service Registry
7.4 Product Registry

8 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY
8.1 Overview
8.2 Population Health Management
8.3 Patient Care Management
8.4 Health Information Exchange
8.5 Point of Care
8.6 Product Outcome Evaluation
8.7 Medical Research and Clinical Studies

9 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY DATABASE TYPE
9.1 Overview
9.2 Commercial
9.3 Public

10 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY END USE
10.1 Overview
10.2 Government & third party administrators
10.3 Hospitals and medical practices
10.4 Private players
10.5 Pharma, Biotech and Medical device companies
10.6 Research Centers

11 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY GEOGRAPHY
11.1 Overview
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 U.K.
11.3.3 France
11.3.4 Rest of Europe
11.4 Asia Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 Rest of Asia Pacific
11.5 Rest of the World
11.5.1 Latin America
11.5.2 Middle East and Africa

12 GLOBAL PATIENT REGISTRY SOFTWARE MARKET COMPETITIVE LANDSCAPE
12.1 Overview
12.2 Company Market Ranking
12.3 Key Development Strategies

13 COMPANY PROFILES

13.1 Phytel, Inc.
13.1.1 Overview
13.1.2 Financial Performance
13.1.3 Product Outlook
13.1.4 Key Developments

13.2 Image Trend, Inc.
13.2.1 Overview
13.2.2 Financial Performance
13.2.3 Product Outlook
13.2.4 Key Developments

13.3 FIGmd, Inc.
13.3.1 Overview
13.3.2 Financial Performance
13.3.3 Product Outlook
13.3.4 Key Developments

13.4 Liaison Technologies
13.4.1 Overview
13.4.2 Financial Performance
13.4.3 Product Outlook
13.4.4 Key Developments

13.5 Cecity.Com, Inc.
13.5.1 Overview
13.5.2 Financial Performance
13.5.3 Product Outlook
13.5.4 Key Developments

13.6 Dacima Software, Inc.
13.6.1 Overview
13.6.2 Financial Performance
13.6.3 Product Outlook
13.6.4 Key Developments

13.7 Global Vision Technologies, Inc. (GVT)
13.7.1 Overview
13.7.2 Financial Performance
13.7.3 Product Outlook
13.7.4 Key Developments

13.8 Ifa Systems AG
13.8.1 Overview
13.8.2 Financial Performance
13.8.3 Product Outlook
13.8.4 Key Developments

13.9 Inc Research Holdings, Inc.
13.9.1 Overview
13.9.2 Financial Performance
13.9.3 Product Outlook
13.9.4 Key Developments

13.10 M2S, Inc
13.10.1 Overview
13.10.2 Financial Performance
13.10.3 Product Outlook
13.10.4 Key Developments

14 Appendix
14.1 Related Research

Keyplayer

  • IQVIA
  • IBM Watson Health
  • Cerner Corporation
  • Epic Systems Corporation
  • Phytel
  • OpenText
  • Global Vision Technologies
  • Dacima Software
  • Inc.
  • Velos
  • Inc.
  • Syapse
  • Premier
  • Inc.
  • Medstreaming
  • FIGmd
  • ArborMetrix
  • Optum
  • Inc.
  • Arbor Research Collaborative for Health
  • Health Catalyst
  • Conduent
  • Inc.
  • ArborMetrix
  • VersaForm Systems Corporation 

 

Table of Content

Will be Available in the sample /Final Report. Please ask our sales Team.
Will be Available in the sample /Final Report. Please ask our sales Team.